Literature DB >> 21954036

Prospective diagnostic performance evaluation of single-voxel 1H MRS for typing and grading of brain tumours.

Margarida Julià-Sapé1, Indira Coronel, Carles Majós, Ana Paula Candiota, Marta Serrallonga, Mònica Cos, Carles Aguilera, Juan José Acebes, John R Griffiths, Carles Arús.   

Abstract

The purpose of this study was to evaluate whether single-voxel (1)H MRS could add useful information to conventional MRI in the preoperative characterisation of the type and grade of brain tumours. MRI and MRS examinations from a prospective cohort of 40 consecutive patients were analysed double blind by radiologists and spectroscopists before the histological diagnosis was known. The spectroscopists had only the MR spectra, whereas the radiologists had both the MR images and basic clinical details (age, sex and presenting symptoms). Then, the radiologists and spectroscopists exchanged their predictions and re-evaluated their initial opinions, taking into account the new evidence. Spectroscopists used four different systems of analysis for (1)H MRS data, and the efficacy of each of these methods was also evaluated. Information extracted from (1)H MRS significantly improved the radiologists' MRI-based characterisation of grade IV tumours (glioblastomas, metastases, medulloblastomas and lymphomas) in the cohort [area under the curve (AUC) in the MRI re-evaluation 0.93 versus AUC in the MRI evaluation 0.85], and also of the less malignant glial tumours (AUC in the MRI re-evaluation 0.93 versus AUC in the MRI evaluation 0.81). One of the MRS analysis systems used, the INTERPRET (International Network for Pattern Recognition of Tumours Using Magnetic Resonance) decision support system, outperformed the others, as well as being better than the MRI evaluation for the characterisation of grade III astrocytomas. Thus, preoperative MRS data improve the radiologists' performance in diagnosing grade IV tumours and, for those of grade II-III, MRS data help them to recognise the glial lineage. Even in cases in which their diagnoses were not improved, the provision of MRS data to the radiologists had no negative influence on their predictions.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21954036     DOI: 10.1002/nbm.1782

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  22 in total

1.  Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.

Authors:  Irene Neuner; Joachim B Kaffanke; Karl-Josef Langen; Elena Rota Kops; Lutz Tellmann; Gabriele Stoffels; Christoph Weirich; Christian Filss; Jürgen Scheins; Hans Herzog; N Jon Shah
Journal:  Eur Radiol       Date:  2012-07-11       Impact factor: 5.315

2.  Non-invasive in vivo assessment of IDH1 mutational status in glioma.

Authors:  Myriam M Chaumeil; Peder E Z Larson; Hikari A I Yoshihara; Olivia M Danforth; Daniel B Vigneron; Sarah J Nelson; Russell O Pieper; Joanna J Phillips; Sabrina M Ronen
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 3.  Clinical decision support systems for brain tumor characterization using advanced magnetic resonance imaging techniques.

Authors:  Evangelia Tsolaki; Evanthia Kousi; Patricia Svolos; Efthychia Kapsalaki; Kyriaki Theodorou; Constastine Kappas; Ioannis Tsougos
Journal:  World J Radiol       Date:  2014-04-28

4.  Combined MRI and MRS improves pre-therapeutic diagnoses of pediatric brain tumors over MRI alone.

Authors:  Mark S Shiroishi; Ashok Panigrahy; Kevin R Moore; Marvin D Nelson; Floyd H Gilles; Ignacio Gonzalez-Gomez; Stefan Blüml
Journal:  Neuroradiology       Date:  2015-07-04       Impact factor: 2.804

5.  Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma.

Authors:  Myriam M Chaumeil; Peder E Z Larson; Sarah M Woods; Larry Cai; Pia Eriksson; Aaron E Robinson; Janine M Lupo; Daniel B Vigneron; Sarah J Nelson; Russell O Pieper; Joanna J Phillips; Sabrina M Ronen
Journal:  Cancer Res       Date:  2014-05-29       Impact factor: 12.701

6.  Pediatric posterior fossa incidentalomas.

Authors:  Danil A Kozyrev; Shlomi Constantini; Deki Tsering; Robert Keating; Sharif Basal; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2019-09-06       Impact factor: 1.475

Review 7.  An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care.

Authors:  Hossein Shooli; Habibollah Dadgar; Yì-Xiáng J Wáng; Manochehr Seyedi Vafaee; Saman Rassaei Kashuk; Reza Nemati; Esmail Jafari; Iraj Nabipour; Ali Gholamrezanezhad; Majid Assadi; Mykol Larvie
Journal:  Quant Imaging Med Surg       Date:  2019-09

Review 8.  Clinical proton MR spectroscopy in central nervous system disorders.

Authors:  Gülin Oz; Jeffry R Alger; Peter B Barker; Robert Bartha; Alberto Bizzi; Chris Boesch; Patrick J Bolan; Kevin M Brindle; Cristina Cudalbu; Alp Dinçer; Ulrike Dydak; Uzay E Emir; Jens Frahm; Ramón Gilberto González; Stephan Gruber; Rolf Gruetter; Rakesh K Gupta; Arend Heerschap; Anke Henning; Hoby P Hetherington; Franklyn A Howe; Petra S Hüppi; Ralph E Hurd; Kantarci Kantarci; Dennis W J Klomp; Roland Kreis; Marijn J Kruiskamp; Martin O Leach; Alexander P Lin; Peter R Luijten; Malgorzata Marjańska; Andrew A Maudsley; Dieter J Meyerhoff; Carolyn E Mountford; Sarah J Nelson; M Necmettin Pamir; Jullie W Pan; Andrew C Peet; Harish Poptani; Stefan Posse; Petra J W Pouwels; Eva-Maria Ratai; Brian D Ross; Tom W Scheenen; Christian Schuster; Ian C P Smith; Brian J Soher; Ivan Tkáč; Daniel B Vigneron; Risto A Kauppinen
Journal:  Radiology       Date:  2014-03       Impact factor: 11.105

9.  Diagnostic accuracy and added value of qualitative radiological review of 1H-magnetic resonance spectroscopy in evaluation of childhood brain tumors.

Authors:  Karen A Manias; Simrandip K Gill; Lesley MacPherson; Adam Oates; Benjamin Pinkey; Paul Davies; Niloufar Zarinabad; Nigel P Davies; Ben Babourina-Brooks; Martin Wilson; Andrew C Peet
Journal:  Neurooncol Pract       Date:  2019-05-09

10.  Diagnosing relapse in children's brain tumors using metabolite profiles.

Authors:  Simrandip K Gill; Martin Wilson; Nigel P Davies; Lesley MacPherson; Martin English; Theodoros N Arvanitis; Andrew C Peet
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.